Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing

Abstract

About

This paper, published in 1950, received 188 indexed citations. Written by John J. Lima, Cameron D. Thomas, Julia M. Barbarino, Zeruesenay Desta, Sara L. Van Driest, Nihal El Rouby, Julie A. Johnson, Larisa H. Cavallari, Valentina Shakhnovich and David Thacker covering the research area of Gastroenterology, Pulmonary and Respiratory Medicine and Surgery. It is primarily cited by scholars working on Pharmacology (103 citations), Surgery (64 citations) and Pediatrics, Perinatology and Child Health (56 citations). Published in Clinical Pharmacology & Therapeutics.

In The Last Decade

doi.org/10.1002/cpt.2015 →

Countries where authors are citing Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing

Since Specialization

Citations

This map shows the geographic impact of Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing more than expected).

Fields of papers citing Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1002/cpt.2015.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2 Breakdown of academic impact, for the paper Characterizing the Google Books Corpus: Strong Limits to Inferences of Socio-Cultural and Linguistic Evolution Breakdown of academic impact, for the paper Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines Breakdown of academic impact, for the paper Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity Breakdown of academic impact, for the paper A Survey of Robot Learning Strategies for Human-Robot Collaboration in Industrial Settings Breakdown of academic impact, for the paper How AI Responds to Common Lung Cancer Questions: ChatGPT versus Google Bard Breakdown of academic impact, for the paper Photocatalysis of water into hydrogen peroxide over an atomic Ga-N5 site Breakdown of academic impact, for the paper Effects of ACA Medicaid Expansions on Health Insurance Coverage and Labor Supply